This webinar will highlight recent advances in the development of a one-part chemically defined (CD) microbial medium to simplify workflows and achieve high density cultures ideal for recombinant protein or plasmid production applications supporting therapeutics, gene therapy and vaccine advancement.
Recent performance data will be shared from relevant application studies, including considerable time savings and potential overall cost reductions for the industry. Examples will be provided of how to further improve process productivity and reduce risks with the use of the medium with single-use fermentation systems and innovative feed strategies.
Learning outcomes/topics include:
- Benefits from use of an animal origin free, chemically defined microbial fermentation medium
- Increased efficiency and risk-reduction opportunities gained using an enhanced Single-Use Fermentor (eSUF) with the CD medium
- Small-scale data-based case study outcomes
- Scale-up case studies to 300L and feed strategy
- Results from the medium’s use for AAV and LV production